C12Y 302/01063
1,2-alpha-l-fucosidase
Official title: 1,2-Alpha-L-fucosidase (3.2.1.63)
C12Y302/01063 (1,2-alpha-l-fucosidase) appears on 3 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 10
- Assignees
- 7
- Inventors
- 29
- Latest grant
- 31 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 2 |
| 2022 | 1 | 2 |
| 2023 | 1 | 4 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Insulin formulations and uses in infusion devices31 Dec 2024US 12,178,852 B2Willow Laboratories, Inc.
- Method for treating subject suffering from flavivirus infection22 Aug 2023US 11,730,811 B2Kaohsiung Medical University
- Hyaluronidase compositions and methods of using same for determining the etiology of peri-orbital puffiness5 Apr 2022US 11,291,403 B2Standard of Care Corporation
- Insulin formulations and uses in infusion devices24 Apr 2025US 2025/0127861 A1Willow Laboratories, Inc.
- Uses of bifidobacterium longum transitional microorganism19 Sep 2024US 2024/0306694 A1Societe des Produits Nestle S. A.
- Treatment or prevention of hiv infection21 Dec 2023US 2023/0405001 A1Janssen Sciences Ireland Unlimited Company
- Compositions and methods for treating serrated colorectal cancer16 Nov 2023US 2023/0364205 A1Sanford Burnham Prebys Medical Discovery Institute
- Stable formulations of programmed death receptor 1 (pd-1) antibodies and hyaluronidase variants and fragments thereof and methods of use thereof16 Nov 2023US 2023/0365692 A1Merck Sharp & Dohme Corp.
Most cited
By later US patents